Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Lymphoma

  Free Subscription


1 Am J Hematol
1 Biochem Biophys Res Commun
2 Blood
1 Br J Cancer
1 Br J Haematol
1 Cancer
1 Eur J Haematol
1 Hum Pathol
1 Int J Radiat Oncol Biol Phys
1 Leuk Lymphoma
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Hematol

  1. SIEGELE BJ, Nardi V
    Laboratory Testing in BCR-ABL1-like (Philadelphia-like) B-Lymphoblastic Leukemia/Lymphoma.
    Am J Hematol. 2018 Apr 26. doi: 10.1002/ajh.25126.
    PubMed     Text format     Abstract available

    Biochem Biophys Res Commun

  2. YASUI K, Izumida M, Nakagawa T, Kubo Y, et al
    MicroRNA-3662 expression correlates with antiviral drug resistance in adult T-cell leukemia/lymphoma cells.
    Biochem Biophys Res Commun. 2018 Apr 20. pii: S0006-291X(18)30940.
    PubMed     Text format     Abstract available


  3. PHILLIPS TJ, Forero-Torres A, Sher T, Diefenbach CS, et al
    Phase 1 study of the PI3Kdelta inhibitor INCB040093 +/- JAK1 inhibitor itacitinib in relapsed/refractory B-cell lymphoma.
    Blood. 2018 Apr 25. pii: blood-2017-10-812701. doi: 10.1182/blood-2017-10-812701
    PubMed     Text format     Abstract available

  4. HIGUCHI H, Yamakawa N, Imadome KI, Yahata T, et al
    Role of exosomes as a proinflammatory mediator in the development of EBV-associated lymphoma.
    Blood. 2018 Apr 22. pii: blood-2017-07-794529. doi: 10.1182/blood-2017-07-794529
    PubMed     Text format     Abstract available

    Br J Cancer

  5. ORECCHIONI S, Talarico G, Labanca V, Calleri A, et al
    Vinorelbine, cyclophosphamide and 5-FU effects on the circulating and intratumoural landscape of immune cells improve anti-PD-L1 efficacy in preclinical models of breast cancer and lymphoma.
    Br J Cancer. 2018 Apr 26. pii: 10.1038/s41416-018-0076.
    PubMed     Text format     Abstract available

    Br J Haematol

  6. MCMASTER ML, Sun C, Landi MT, Savage SA, et al
    Germline mutations in Protection of Telomeres 1 in two families with Hodgkin lymphoma.
    Br J Haematol. 2018;181:372-377.
    PubMed     Text format     Abstract available


  7. ARTS LPJ, Oerlemans S, Tick L, Koster A, et al
    More frequent use of health care services among distressed compared with nondistressed survivors of lymphoma and chronic lymphocytic leukemia: Results from the population-based PROFILES registry.
    Cancer. 2018 Apr 26. doi: 10.1002/cncr.31410.
    PubMed     Text format     Abstract available

    Eur J Haematol

  8. JAMROZIAK K, Szymczyk A, Hus M, Wojciechowska M, et al
    Hodgkin's variant of Richter's transformation during ibrutinib therapy in a series of CLL patients; the Polish Adult Leukemia Group report (PALG).
    Eur J Haematol. 2017 Dec 15. doi: 10.1111/ejh.13016.
    PubMed     Text format     Abstract available

    Hum Pathol

  9. KADIN ME, Morgan J, Xu H, Epstein AL, et al
    IL-13 is produced by tumor cells in Breast Implant Associated Anaplastic Large Cell Lymphoma: Implications for pathogenesis.
    Hum Pathol. 2018 Apr 21. pii: S0046-8177(18)30127.
    PubMed     Text format     Abstract available

    Int J Radiat Oncol Biol Phys

  10. PINNIX CC, Cella L, Andraos TY, Ayoub Z, et al
    Predictors of Hypothyroidism in Hodgkin Lymphoma Survivors After Intensity Modulated Versus 3-Dimensional Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2018 Mar 14. pii: S0360-3016(18)30495.
    PubMed     Text format     Abstract available

    Leuk Lymphoma

  11. LUDMIR EB, Milgrom SA, Pinnix CC, Gunther JR, et al
    Primary breast diffuse large B-cell lymphoma: treatment strategies and patterns of failure().
    Leuk Lymphoma. 2018 Apr 26:1-8. doi: 10.1080/10428194.2018.1460825.
    PubMed     Text format     Abstract available

    PLoS One

  12. GARDNER HL, Rippy SB, Bear MD, Cronin KL, et al
    Phase I/II evaluation of RV1001, a novel PI3Kdelta inhibitor, in spontaneous canine lymphoma.
    PLoS One. 2018;13:e0195357.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.